Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
Seminars in Oncology|November 24, 1999
The current status of adjuvant chemotherapy for resected non-small cell lung cancerM A SocinskiLung Cancer (Amsterdam, Netherlands)|November 18, 2005
Seeking new options for the treatment of small-cell lung cancerM A SocinskiCurrent Oncology (Toronto, Ont.)|October 11, 2014
Update on taxanes in the first-line treatment of advanced non-small-cell lung cancerM A SocinskiThe Oncologist|November 7, 1999
Single-agent paclitaxel in the treatment of advanced non-small cell lung cancerM A SocinskiClinical Pharmacology and Therapeutics|April 20, 2016
The clinical utility of PD-L1 testing in selecting non-small cell lung cancer patients for PD1/PD-L1-directed therapyL C Villaruz, M A SocinskiSeminars in Oncology|August 1, 1997
High-dose therapy with carboplatin and paclitaxel in non-small cell lung cancerM A Socinski, T C SheaSeminars in Oncology|December 10, 1999
Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancerM A Socinski, C J LangerCurrent Opinion in Pulmonary Medicine|July 17, 1999
Combined-modality therapy in the nonsurgical management of unresectable stage III non-small cell lung cancerT A Hensing, M A SocinskiChest|July 1, 1997
IIB or not IIB: the current question in staging non-small cell lung cancerF C Detterbeck, M A SocinskiOncogene|May 29, 2007
Bevacizumab in the treatment of non-small-cell lung cancerT E Stinchcombe, M A SocinskiPageof 6